| Product Code: ETC12838628 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The Gambia`s influenza medications market witnessed a significant decline in imports during 2020-2024. The Compound Annual Growth Rate (CAGR) for this period was -21.06%. Particularly in 2023-2024, there was a sharp year-on-year decrease of -47.77%, contributing to the overall downward trend in import volumes.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gambia Influenza Medications Market Overview |
3.1 Gambia Country Macro Economic Indicators |
3.2 Gambia Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Gambia Influenza Medications Market - Industry Life Cycle |
3.4 Gambia Influenza Medications Market - Porter's Five Forces |
3.5 Gambia Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Gambia Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Gambia Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Gambia Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of influenza cases in Gambia |
4.2.2 Growing awareness about the importance of early treatment for influenza |
4.2.3 Expansion of healthcare infrastructure and access to healthcare services in Gambia |
4.3 Market Restraints |
4.3.1 Limited availability of specific influenza medications in the market |
4.3.2 High cost associated with some influenza medications |
4.3.3 Regulatory challenges and stringent approval processes for new medications |
5 Gambia Influenza Medications Market Trends |
6 Gambia Influenza Medications Market, By Types |
6.1 Gambia Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Gambia Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Gambia Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Gambia Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Gambia Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Gambia Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Gambia Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Gambia Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Gambia Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Gambia Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Gambia Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Gambia Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Gambia Influenza Medications Market Import-Export Trade Statistics |
7.1 Gambia Influenza Medications Market Export to Major Countries |
7.2 Gambia Influenza Medications Market Imports from Major Countries |
8 Gambia Influenza Medications Market Key Performance Indicators |
8.1 Number of influenza cases diagnosed and treated annually |
8.2 Adoption rate of influenza vaccination in the population |
8.3 Percentage of healthcare facilities equipped to diagnose and treat influenza |
9 Gambia Influenza Medications Market - Opportunity Assessment |
9.1 Gambia Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Gambia Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Gambia Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Gambia Influenza Medications Market - Competitive Landscape |
10.1 Gambia Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Gambia Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here